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Dear Editor,
The mammalian target of rapamycin (mTOR), as a critical
energy sensor and cell-growth regulator, controls protein
synthesis, autophagy and many important cellular processes
through forming functional distinct complexes, mTORC1 and
mTORC2. mTORC1 that is sensitive to rapamycin, regulates
cell growth and protein synthesis, while mTORC2 that is
insensitive to rapamycin, regulates cellular metabolism and
the cytoskeletal organization (Gingras et al., 2001; Hay and
Sonenberg, 2004). Translation initiation is the rate-limiting
step in protein synthesis, which proceeds through a multi-
step process that can be divided into three major steps. First,
eukaryotic translation initiation factor 2 (eIF2) binds with GTP
and methionyl-tRNA to form the ternary complex, which
further binds to 40S ribosomal subunit with the help of eIF1,
eIF1A, eIF3 and eIF5 resulting the preinitiation complex
(PIC). Second, the PIC binds to mRNA which is unwinded by
the eIF4F complex (including eIF4E, eIF4G, eIF4A, eIF4B).
Finally, the second GTPase, eIF5B catalyzes the joining of
the 60S subunit and 40S subunit to form the 80S initiation
complex (Jackson et al., 2010). mTORC1 regulates activities
of a number of constituents of protein synthesis, including
translation initiation factors and elongation factors, through
phosphorylating two well-known substrates, the ribosomal
S6 kinases (S6K1 and S6K2) and the eukaryotic initiation
factor 4E binding proteins (4E-BP1 and 4E-BP2) (Gingras
et al., 2001; Hay and Sonenberg, 2004). Phosphorylation of
4E-BP1 by mTORC1 increases the availability of eIF4E.
Phosphorylation of eIF4B by S6K1 is necessary for PIC
formation (Gingras et al., 2001). Ribosomal protein S6
(RPS6) which is the substrate of S6K1 and S6K2, involves in
the regulation of cell proliferation, cell size and glucose
homeostasis (Ruvinsky et al., 2005). However, systematic
analysis of mTORC1 mediated phosphorylation in ribosomal
and associated proteins has not been achieved.
To analyze mTORC1-mediated phosphorylation in riboso-
mal and associated proteins, quantitative phosphoproteomic
analysis basedon theSILAC (stable isotope labeling byamino
acids in cell culture) method was carried out to analyze afﬁnity
enriched phosphoproteins from the untreated and rapamycin-
treated 293Tcells. The experimental workﬂow was displayed
in Fig. 1A. Brieﬂy, cells grown in light medium (12C6
14N2-Lysine
and 12C6-Arginine, K
0R0) were treated with 200 nmol/L rapa-
mycin for 2 h, while cells grown in heavy medium (13C6
15N2-
Lysine and 13C6-Arginine, K
8R6) were untreated. Sucrose
cushion centrifugation was used to isolate ribosomes. Pro-
teins extracted from the whole cell lysate or the isolated ribo-
some fraction of the untreated and rapamycin-treated cells
were mixed and trypsin digested. Then phosphopeptides
were enrichedwith TiO2 beads and analyzed by nano-LC-MS/
MS. The generated MS/MS spectra were searched against
the human database using the Sequest search engine in the
Proteome Discoverer (Version 1.4) software, with the false
discovery rate (FDR) setting to 0.01.
We identiﬁed 61 unique phosphorylation sites on 37 ribo-
somal proteins, among which 33 phosphorylation sites have
been reported before in the Uniprot database (http://www.
uniprot.org). Abundance of 28 phosphorylated peptides cor-
responding to 31 phosphorylation sites were decreased after
rapamycin-treatment (Fig. 1B), of which 12 were from 9 pro-
teins of the 40S ribosome, and 16 were from 12 proteins of the
60S ribosome. Quantitative proteomics using Tandem Mass
Tags (TMT) was carried out and showed that 2-h rapamycin
treatment did not induce changes in the expression levels of
ribosomal proteins (Table S1). This indicated that phospho-
rylation changes in these proteins were caused by inhibition of
mTOR. We further identiﬁed that 14 phosphorylated peptides
possessed three types of consensus sequence motifs using
iceLogo (http://iomics.ugent.be/icelogoserver/) (Fig. 1C and
Table S2), including proline-directed motif (SP and TP), which
was the known mTOR targeted phosphorylation sites, the
ribosomal S6 kinase (RSK)-targeted arginine-rich motif
(RRRxS), and the acidic motif (SxxD/E/pS) that was the
potential substrate of casein kinase II (CKII) predicted using
KinasePhos (http://kinasephos.mbc.nctu.edu.tw/).
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RPS2 S77 IKpSLEEIYLFSLPIK 0.68 RPL13 S139 KGDpSSAEELKLATQLTGPVM
PVR
0.59
RPS2 S264 ETVFTKpSPYQEFTDHLVK 0.68 RPL14 S139 AALLKApSPK 0.52
RPS3 T221 DEILPTpTPISEQK 0.54 RPL15 S97 FARpSLQSVAEER 0.56
RPS3A S236 LMELHGEGpSSSGK 0.64 RPL18A S71 SSGEIVYCGQVFEKpSPLRVK 0.57
RPS6 S148 KLFNLpSKEDDVR 0.04 RPL18A S123 AHpSIQIMK 0.67
RPS6 S235 RLpSSLRASTSK 0.03 RPL19 S13 LASpSVLR 0.63
RPS6 S236 
S240
LSpSLRA pSTSK 0.04 RPL23A S43 KIRTpSPTFR 0.58
RPS8 S160 ISpSLLEEQFQQGK 0.51 RPL24 S86 AITGApSLADIMAK 0.42
RPS9 S153 LDpSQKHIDFSLR 0.64 RPL26 T139 GKYKEEpTIEK 0.69
RPS10 S146 KAEAGAGpSATEFQFR 0.72 RPL28 S115 RApSAILR 0.64
RPS17 S113 LLDFGpSLSNLQVTQPTVG
MNFK
0.69 RPL34 S12 RLpSYNTASNK 0.45
RPS27 S27 LVQpSPNSYFMDVK 0.57 RPLP0 S304 
S307
VEAKEEpSEEpSDEDMGFGLFD 0.40
RPL13 S77 AGRGFpSLEELR 0.51 RPLP2 S17 YVASYLLAALGGNSpSPSAK 0.47







Ribosome Whole lysate Whole lysateRibosome
Heavy K8R6 Light K8R6
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Furthermore, out of the 31 mTORC1-mediated phospho-
rylation sites, 20 were on the surface of the 80S ribosome as
highlighted with red color (Fig. 1D), which was downloaded
from the Protein Data Bank (accession number: 4V6X). This
suggests that mTOR and associated kinases facilely access
and directly phosphorylate the 80S ribosome. Phosphoryla-
tion sites RPS6 Ser148, Ser235, Ser236, RPS8 Ser160 and
RPL24 Ser86 were on the interface between 40S subunit
and 60S subunit, indicating that mTOR mediated the inter-
action of 40S and 60S subunits. Phosphorylation of the
C-terminal residues in RPS6 by mTOR is known to enhance
the binding of 40S ribosome to the m7GpppG cap of mRNA
for facile translation initiation (Hutchinson et al., 2011).
Rapamycin-responsive RPS8 Ser160 and RPL24 Ser86
were in close proximity to the C-terminus of RPS6, sug-
gesting mTOR-mediated RPS8 and RPL24 phosphorylation
may also involve in mRNA binding. In summary, our phos-
phoproteomic results suggest that mTOR mediated the for-
mation of the 80S ribosome and its binding with mRNA.
We identiﬁed 8353 unique phosphorylated peptides from
2761 distinct proteins extracted from the whole cell lysate.
Abundance of ten phosphorylation peptides corresponding
to eleven phosphorylation sites on seven translation initiation
factors eIF2A, eIF3C, eIF3E, eIF4B, eIF4G1, eIF4G2 and
eIF5B were decreased after rapamycin treatment (Fig. 2A
and Table S3) and designated as mTOR regulated. eIF5B is
responsible for the joining of 60S subunits with the pre-40S
subunits and plays an important role in both of the cap-de-
pendent and the internal ribosome entry site (IRES) depen-
dent translation initiation (Jackson et al., 2010; Thakor and
Holcik, 2012). In the present study, phosphorylation in four
serine residues of eIF5B was decreased upon rapamycin
treatment including phosphorylation on Ser214 residue, in
consistent with the early report on mTOR or mitotic associ-
ated phosphoproteomics (Hsu et al., 2011; Kettenbach et al.,
2011). A MS/MS spectrum that matched to the fragments of
the peptide (NKPGPNIEpSGNEDDDASFK) containing
phosphorylated Ser214 was shown in Fig. S1. Then we used
the method of parallel reaction monitoring (PRM) based
mass spectrometry combined with tandem mass tags (TMT)
labeling to determine the intensity ratio of the phosphoryla-
tion peptide vs. the non-phosphopeptide and conﬁrmed that
the phosphorylation ratio was decreased from 0.3 to 0.1
upon rapamycin-treatment (Fig. S2).
The mTOR-mediated phosphorylation in eIF2, eIF3,
eIF4B and eIF4G has been reported before (Gingras et al.,
2001; Hay and Sonenberg, 2004; Ozcan et al., 2008; Mar-
tineau et al., 2014). The present study also revealed that
mTOR-inhibition decreases the phosphorylation in eIF5B. To
explore effects of Ser214 phosphorylation on eIF5B func-
tions, we used the CRISPR-cas9 technology to knockdown
the expression of eIF5B, showing that the expression level of
eIF5B in eIF5B-knockdown cells was one third of that in the
control cells as determined by qPCR (Fig. S3). Then, plas-
mids containing the wildtype eIF5B, and two mutants eIF5B-
S214A and eIF5B-S214E were transiently transfected into
the eIF5B-knockdown cells, respectively, followed by
immunoprecipitation to identify the binding partners of eIF5B
and mutants. The mRNA level and protein expression of wild
type eIF5B and two mutants were detected by qPCR,
Western blotting and mass spectrometry, as shown in
Figs. S3, S4 and S5. The binding partners of the wild type
eIF5B and two mutants were identiﬁed by label free quan-
tiﬁcation (LFQ) using the MaxQuant software. When a pro-
tein was only present in the eIF5B immunoprecipitated
complex or the total ion intensity of corresponding tryptic
peptides from one protein identiﬁed in the eIF5B immuno-
precipitated complex is ﬁve times higher than that in the
FLAG-only immunoprecipitated complex, this protein was
considered as the binding partner of eIF5B. Forty ﬁve bind-
ing partners (Table S4) of the wild type eIF5B were identiﬁed
in two independent biological replicates and the interactome
was analyzed using STRING software (http://string.embl.de)
(Fig. S6). To understand the biological relevance of these
proteins, the Gene Ontology (GO) was used to cluster pro-
teins according to their associated biological processes. The
annotations of gene lists were summarized via a pie plot
based on KEGG pathway analysis as shown in Fig. 2B.
Eighty percent of eIF5B-binding proteins participated in the
genetic information processing, including ribosome biogen-
esis, messenger RNA biogenesis and spliceosome. In
comparing to proteins binding to the wild type eIF5B, several
proteins were found to preferentially bind to eIF5B-S214E
mutant, but not eIF5B-S214A mutant as displayed in Fig. 2C.
These proteins were considered to have the higher afﬁnity to
Ser214-phosphorylated eIF5B. Among them, N-acetyltrans-
ferase 10 (Nat10), a RNA acetyltransferase, is responsible
for 18S rRNA processing through inducing N4-acetylcytidine
formation (Ito et al., 2014). The Nat10-eIF5B interaction was
veriﬁed by reciprocal immunoprecipitation (Fig. 2D) and
eIF5B was immunoprecipitated by Nat10-speciﬁc antibody in
Nat10-transfected 293T cells. Using PRM-based targeted
mass spectrometry, we found that the ratio of the phospho-
rylated Ser214-containing peptide to the unphosphorylated
peptide in the Nat10-immunoprecipitated eIF5B was 3 times
higher than that in eIF5B from 293T cells, which conﬁrmed
that Nat10 preferred to bind to Ser214 phosphorylated eIF5B
(Fig. 2E). It was reported that the mTOR pathway involved in
Figure 1. Phosphoproteomics analysis of ribosomal pro-
teins after rapamycin treatment. (A) A schematic of the
experimental procedure; (B) A list of mTOR-mediated phos-
phopeptides from ribosomal proteins; (C) Kinases and motifs
analysis of mTOR-mediated phosphorylated peptides; (D) Loca-
tions of the mTOR-mediated phosphoresidues on human 80S
ribosome. Proteins of the 40S subunit are shown in green,
proteins of the 60S subunit are shown in blue, elongation factor
2 and guanine nucleotide-binding protein subunit beta-2-like 1
are shown in orange, and the mTOR-mediated phospho-
residues are shown as red balls. The expanded view shows
the location of phosphorylation sites on RPS6, RPS8 and
RPL24.
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DDX27 ATP-dependent RNA helicase DDX27 5.08 × 105 1.04 × 107 0 8.09 × 106
DDX54 ATP-dependent RNA helicase DDX54 1.48 × 106 1.18 × 107 3.68 × 105 1.05 × 107
EXOS10 Exosome component 10 8.19 × 105 2.01 × 107 2.44 × 106 1.73 × 107
FXR2 Fragile X mental retardation syndrome-related protein 2 4.09 × 106 3.62 × 107 6.70 × 106 2.17 × 107
NAT10 N-acetyltransferase 10 5.26 × 105 1.52 × 107 2.06 × 106 1.10 × 107
NEMF Nuclear export mediator factor NEMF 0 2.74 × 106 0 1.09 × 106
RBM28 RNA-binding protein 28 3.27 × 106 2.06 × 107 0 1.56 × 107
SMCA5 SWI/SNF-related matrix-associated actin-dependent
regulator of chromatin subfamily A member 5 4.05 × 106 2.04 × 107 0 2.04 × 107
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rRNA maturation with unknown mechanism (Iadevaia et al.,
2012). Our results suggested that mTOR phosphorylated
eIF5B to enhance the binding of eIF5B with Nat10 and to
promote rRNA processing.
Taken together, we applied quantitative phosphopro-
teomics to proﬁle rapamycin-inhibition mediated phospho-
rylation changes in ribosomal proteins and suggested that
mTOR mediated the 80S ribosome formation and its binding
to mRNA. We further mapped mTOR-regulated phosphory-
lation sites in eukaryotic translation initiation factors and
identiﬁed that phosphorylation of Ser214 on eIF5B enhanced
the binding of eIF5B to the RNA-binding and processing
proteins including Nat10. Our results suggest that the inter-
action of phosphorylated eIF5B with Nat10 promotes rRNA
processing and rRNA maturation.
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